FEhealthcare.comNov 9, 2021SMTA urges NPPA for 70% margin on MRP instead of 70% on price to distributor for viability...SMTA move is aimed at ensuring viability of the trade channel specifically with reference to SMEs and long term interests of consumers.Surgical Manufacturers & Traders Association (SMTA) has urged the National Pharmaceutical Pricing Authority (NPPA) for 70% margin on market retail price (MRP) basis instead of 70% on price to distributor (PTD) basis with reference to Trade Margin Rationalisation (TMR) of five Medical Devices.These medical devices are BP Monitors, Thermometers, Glucometers, Nebulizers and Pulse Oximeters.SMTA move is aimed at ensuring viability of the trade channel specifically with reference to SMEs and long term interests of consumers.Read more at FEhealthcare.com
SMTA move is aimed at ensuring viability of the trade channel specifically with reference to SMEs and long term interests of consumers.Surgical Manufacturers & Traders Association (SMTA) has urged the National Pharmaceutical Pricing Authority (NPPA) for 70% margin on market retail price (MRP) basis instead of 70% on price to distributor (PTD) basis with reference to Trade Margin Rationalisation (TMR) of five Medical Devices.These medical devices are BP Monitors, Thermometers, Glucometers, Nebulizers and Pulse Oximeters.SMTA move is aimed at ensuring viability of the trade channel specifically with reference to SMEs and long term interests of consumers.Read more at FEhealthcare.com
